A new drug for treating breast cancer sufferers has been licensed for use in Scotland. About 3,500 women in Scotland are diagnosed with breast cancer each year. The makers of Arimidex claim it is 26% more effective in preventing a recurrence in older women who have had a mastectomy than current medications. The drug, which is yet to be approved for use in England and Wales, has been welcomed by Breast Cancer Care Scotland. The drug has been licensed by the Scottish Medicines Consortium. Lorraine Dallas, national co-ordinator of BCCS said: “This is great news for women in Scotland.
